A. Miralles et al., NO EFFECT OF GENETIC OBESITY AND MAZINDOL ON IMIDAZOLINE-I(2) BINDING-SITES IN THE BRAIN OF ZUCKER RATS, European journal of pharmacology, 243(3), 1993, pp. 305-308
The density and affinity states of imidazoline I2 binding sites as wel
l as the density of alpha2-adrenoceptors were quantitated in the brain
of lean and obese Zucker rats. No significant differences were obtain
ed between Zucker phenotypes for these receptors in the cerebral corte
x and hypothalamus. Moreover, chronic treatment with the anorexic imid
azoline derivative, mazindol, did not alter the density of brain imida
zoline I2 binding sites. It is concluded that this genetic model of ob
esity is not associated with abnormal imidazoline I2 binding sites.